Location History:
- Seattle, WA (US) (2018)
- Thousand Oaks, CA (US) (2021 - 2022)
Company Filing History:
3 out of 1,970 
2 out of 541 
Years Active: 2018-2022
Title: Inventor William Rees: Pioneering Innovations in Biomarkers
Introduction
William Rees, an accomplished inventor based in Thousand Oaks, CA, has made significant contributions to the field of biomedical research. With a portfolio of three patents, he has focused his work on developing biomarkers that help in the treatment of interleukin-23 (IL23)-mediated diseases, such as Crohn's disease. His innovative ideas have the potential to transform patient care by providing targeted treatment options.
Latest Patents
William Rees's most recent patents include crucial advancements in using the Chemokine (C-C motif) ligand 20 (CCL20) as a predictor of clinical responses to IL23-antagonists. This invention emphasizes the importance of CCL20 as a biomarker for stratifying or identifying populations of patients suffering from IL23-mediated diseases. The patent outlines how CCL20 levels can determine eligibility for treatment, guide therapeutic decisions, diagnose treatability, and predict treatment outcomes for patients undergoing therapy.
Another key patent by Rees describes the use of various components of the IL23 pathway, including biomarkers such as IL22, LCN2, and combinations thereof, to assess treatment responses in patients with IL23-mediated diseases. Similar to his previous invention, the threshold levels of these biomarkers enable healthcare providers to make informed decisions about the commencement or modification of treatments, as well as predict the effectiveness of specific therapeutic agents.
Career Highlights
Throughout his career, William Rees has collaborated with leading organizations in the biomedical field, including Amgen Inc. and MedImmune Limited. His work in these respected companies has allowed him to contribute to groundbreaking research and development in the realm of immunology and patient care.
Collaborations
William has worked closely with esteemed colleagues such as Robert W Georgantas, III, and Chris Morehouse. Their combined expertise and efforts have enhanced the innovation process, leading to the creation of impactful patents that aim to improve clinical outcomes for patients suffering from chronic diseases.
Conclusion
William Rees is a notable inventor whose work on biomarkers has the potential to greatly influence treatment pathways for patients with IL23-mediated diseases. With his innovative patents and collaborative spirit, he continues to make strides in the field of biomedical research, paving the way for personalized medicine. The impact of his work is likely to be felt in the medical community and by patients for years to come.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.